Vitamin C as an Adjunct in Periodontal Treatment in Type 2 Diabetes Mellitus Patients
NCT ID: NCT03269799
Last Updated: 2017-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
30 participants
INTERVENTIONAL
2017-08-30
2018-08-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of iPRF With Vitamin C in StageII Grade A Periodontitis
NCT05129267
The Effect of Vitamin C on GCF Total Oxidant Capacity in Smoker Patients With Periodontitis
NCT05009355
Impact of Periodontal Therapy on Patients With Diabetes
NCT04830969
Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy
NCT03343366
Diabetes Mellitus and Periodontitis and Vitamin D Supplementation
NCT06077708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
test group
vitamin C 500 mg oral capsule
Vitamin C 500 MG Oral Capsule
non surgical periodontal treatment+vitamin C 500 mg/day for 2 months
control group
placebo
placebo
non surgical periodontal treatment+placebo for 2 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin C 500 MG Oral Capsule
non surgical periodontal treatment+vitamin C 500 mg/day for 2 months
placebo
non surgical periodontal treatment+placebo for 2 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* periodontitis
Exclusion Criteria
* receive insulin
* diseases that interfere with wound healing, e.g., HIV
* receive one of the followings: tetracycline, acetaminophen, NSAID, warfarin, aluminum-containing antacids, barbiturates, phenobarbital, pentobarbital, secobarbital, hormone replacement therapy, chemotherapeutic drug, protease inhibitor
* receive other vitamins or antibiotics within 6 months
* smoking
* pregnancy
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Supanee Rassameemasmaung
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nis Okuma, DDS, MD, M.Sc (Oral Medicine)
Role: PRINCIPAL_INVESTIGATOR
Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Burapha University Hospital
Chon Buri, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Supanee Rassameemasmaung, DDS, M.Sc (Periodontics), Ph.D
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Pechngam Chaivanit, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/DT068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.